Verition Fund Management LLC Has $11.08 Million Position in Amedisys, Inc. (NASDAQ:AMED)

Verition Fund Management LLC increased its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 608.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,774 shares of the health services provider's stock after purchasing an additional 98,565 shares during the period. Verition Fund Management LLC owned 0.35% of Amedisys worth $11,077,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AMED. Arizona State Retirement System raised its stake in shares of Amedisys by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider's stock worth $840,000 after buying an additional 177 shares in the last quarter. Signaturefd LLC raised its position in Amedisys by 20.9% in the third quarter. Signaturefd LLC now owns 1,367 shares of the health services provider's stock worth $132,000 after acquiring an additional 236 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Amedisys by 0.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider's stock valued at $2,876,000 after acquiring an additional 255 shares during the last quarter. State of Alaska Department of Revenue lifted its holdings in Amedisys by 7.2% in the 3rd quarter. State of Alaska Department of Revenue now owns 3,782 shares of the health services provider's stock valued at $365,000 after acquiring an additional 255 shares during the last quarter. Finally, CWM LLC boosted its position in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider's stock valued at $211,000 after purchasing an additional 277 shares in the last quarter. Institutional investors own 94.36% of the company's stock.

Amedisys Price Performance

AMED stock traded up $0.18 on Friday, hitting $91.41. 107,958 shares of the company's stock traded hands, compared to its average volume of 580,939. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market cap of $2.99 billion, a price-to-earnings ratio of 36.27, a P/E/G ratio of 1.92 and a beta of 0.78. Amedisys, Inc. has a 1-year low of $88.81 and a 1-year high of $98.95. The stock has a fifty day moving average of $94.74 and a 200-day moving average of $95.62.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business's revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 earnings per share. On average, analysts forecast that Amedisys, Inc. will post 4.55 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.